Actively Recruiting
Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
Led by Thomas Hope · Updated on 2026-04-03
199
Participants Needed
1
Research Sites
218 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a single center study investigating the use of Fluoroethyltyrosine (FET) in the detection of brain tumors. FET accumulates in malignant cells within intracranial neoplasms and can be used to detect recurrent disease and characterize grade of glial neoplasms.
CONDITIONS
Official Title
Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Presence or suspicion of intracranial neoplasm in two populations:
- Population 1: Participants after primary treatment (radiation therapy and/or surgery) with suspicion of recurrence on MRI.
- Recurrent metastatic lesions.
- Recurrent high-grade gliomas (Grades 3 and 4).
- Recurrent low-grade gliomas (Grade 2).
- Population 2: Participants prior to primary treatment with planned biopsy or surgical resection.
- Population 1: Participants after primary treatment (radiation therapy and/or surgery) with suspicion of recurrence on MRI.
- Age over 3 years.
- Participants in other clinical trials, including surgery guided by 5-aminolevulinic acid, are eligible.
You will not qualify if you...
- Known incompatibility to PET or CT/MRI scans.
- Unlikely to comply with study procedures, restrictions, and requirements as judged by the Investigator.
- Sedation or anesthesia may be used for participants who cannot tolerate the exam.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California, San Francisco
San Francisco, California, United States, 94143
Actively Recruiting
Research Team
L
Louise Magat
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here